1.
Zentralbl Gynakol
; 124(10): 473-7, 2002 Oct.
Artigo
em Alemão
| MEDLINE
| ID: mdl-12712389
RESUMO
Breast cancer is the most frequent gynecological tumor. The HER-2/neu oncogene may play a role in the prognosis and management of patients with breast cancer. In a retrospective study on 100 patients, we correlated the expression of this oncogene with the classic clinical and pathological factors. 32 % of patients exhibited overexpression of HER-2/neu. There was no significant correlation with classic parameters. This finding could indicate that HER-2/neu expression is a new independent prognostic factor. Prospective studies correlating HER-2/neu overexpression with prognosis might provide additional data.
Assuntos
Neoplasias da Mama/patologia , Receptor ErbB-2/análise , Receptores de Estrogênio/análise , Receptores de Progesterona/análise , Neoplasias da Mama/genética , Divisão Celular , Feminino , Genes erbB-2 , Humanos , Imuno-Histoquímica/métodos , Metástase Linfática , Pessoa de Meia-Idade , Estadiamento de Neoplasias
2.
CCQ
; 3(4): 35-45, 1981 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-10249950
3.
J Nurs Educ
; 19(6): 15-25, 1980 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-6250999